Formycon

About:

Formycon provides formulation and analytical services to the biopharmaceutical industry.

Website: https://www.formycon.com

Top Investors: Richter Group, Bavarian Research Foundation

Description:

Formycon GmbH is more than a regular CRO that provides formulation and analytical services to the biopharmaceutical industry. The complete analytical development chain – starting from protein characterization and comparability studies up to GMP Quality Control and stability testing of clinical study and market medication. The Formulation one-stop shop – Formycon covers pre-formulation, development of systemic and local, liquid, freeze-dried and sustained release drug product formulations, supply of pre-clinical studies and development of the manufacturing process.

Total Funding Amount:

83.1M EUR

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Martinsried, Bayern, Germany

Founded Date:

1999-01-01

Founders:

Number of Employees:

101-250

Last Funding Date:

2024-01-29

IPO Status:

Public

Industries:

© 2025 bioDAO.ai